Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

SHPCX vs. IBB: which is better?

Bottom line

SHPCX vs IBB: the short answer

SHPCX (Health & Biotechnology Portfolio) and IBB (iShares Biotechnology ETF) are both mutual funds.

But IBB is far broader, holding 254 positions to 29 for SHPCX, so beyond the top names it adds exposure SHPCX doesn't have.

IBB is cheaper at 0.44% vs 3.6% — a difference of $316 a year per $10,000 invested.

Over five years, SHPCX returned +3.7% a year vs +2.5% for IBB (reporting dates differ).

Updated Nov 19, 2026

SHPCX vs IBB side by side

SHPCXIBB
TypeMutual fundETF
Fund familySaratoga AdvantageiShares
CategoryTechnology SectorTechnology Sector
Expense ratio3.6%0.44%
Annual cost per $10k$360$44
10-yr cost on $10k (prospectus)$3,862$555
Max front load0%None
12b-1 fee—0%
1-yr return−1.3%+28.0%
5-yr return (annualized)+3.7%+2.5%
10-yr return (annualized)+4.1%+4.4%
Best quarter+15.0%+26.8%
Worst quarter−13.0%−22.9%
Net assets (fund)$10.5M$5.9B
Number of holdings29254
Portfolio turnover22%27%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearSHPCXIBBDifference
2024−0.3%−2.4%+2.1%
2023−0.9%+3.6%−4.6%
2022+1.4%−13.6%+15.0%
2021+16.0%+1.0%+15.0%
2020+3.0%+25.9%−22.9%
2019+15.4%+24.8%−9.3%
2018−6.0%−9.1%+3.2%
2017+11.3%+21.2%−10.0%
2016−2.5%−21.5%+19.0%
2015+6.3%+11.5%−5.2%

Source: Fund prospectus bar charts

Holdings overlap

8 of SHPCX's top 25 holdings also appear in IBB's top 25.

Shared top holdings
HoldingSHPCXIBB
United Therapeutics Corp6.17%1.82%
Amgen Inc5.04%7.50%
Exelixis Inc4.55%1.07%
Gilead Sciences Inc3.94%7.52%
Regeneron Pharmaceuticals Inc3.93%5.70%
Medpace Holdings Inc3.37%1.16%
Vertex Pharmaceuticals Inc3.36%7.66%
Incyte Corp2.89%1.62%

Source: SEC Form N-PORT

SHPCX top 10

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. United Therapeutics Corp — 6.17%
  4. Amgen Inc — 5.04%
  5. Mckesson Corp — 4.90%
  6. Lantheus Holdings Inc — 4.64%
  7. Exelixis Inc — 4.55%
  8. Novartis Ag — 4.50%
  9. Cencora Inc — 4.33%
  10. Gilead Sciences Inc — 3.94%

IBB top 10

  1. BlackRock Funds III — 13.18%
  2. Vertex Pharmaceuticals, Inc. — 7.66%
  3. Gilead Sciences, Inc. — 7.52%
  4. Amgen, Inc. — 7.50%
  5. Regeneron Pharmaceuticals, Inc. — 5.70%
  6. Alnylam Pharmaceuticals, Inc. — 5.68%
  7. IQVIA Holdings, Inc. — 3.18%
  8. Argenx SE — 3.15%
  9. Insmed, Inc. — 2.95%
  10. Mettler-Toledo International, Inc. — 2.49%

FAQ

What is the difference between SHPCX and IBB?
SHPCX (Health & Biotechnology Portfolio) and IBB (iShares Biotechnology ETF) are both mutual funds. But IBB is far broader, holding 254 positions to 29 for SHPCX, so beyond the top names it adds exposure SHPCX doesn't have.
Which is cheaper, SHPCX or IBB?
IBB has the lower expense ratio (0.44%).
Should I own both SHPCX and IBB?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.